Does EmblemHealth Cover Ozempic?
The verdict
Conditional on most plans
EmblemHealth covers Ozempic for type 2 diabetes with prior authorization — it does not cover Ozempic for off-label weight-loss use under any EmblemHealth line of business. As the dominant HMO insurer in the New York City area, EmblemHealth's formulary operates under New York's strong insurance regulations, supporting consistent coverage of established T2D medications. Formulary tier and cost-share are not publicly confirmed at the drug level; verify on EmblemHealth's drug-lookup tool.
Coverage is set by your specific plan and formulary. This is a research summary — always confirm with EmblemHealth using your member ID.
Key facts
Ozempic is FDA-approved for type 2 diabetes glycemic control and cardiovascular risk reduction in T2D patients — not for weight loss.
FDA drug labeling (semaglutide injection)
The IRA Maximum Fair Price for semaglutide under Medicare is $274 per 30-day supply, effective January 1, 2027 — a 71% discount off the CY2024 list price of ~$959.
CMS, IRA Drug Price Negotiation Program, 2024
All 50 state Medicaid programs cover GLP-1s including Ozempic for type 2 diabetes; none cover Ozempic for off-label weight loss.
KFF, Medicaid Coverage of and Spending on GLP-1s
Medicare vs. commercial coverage
Whether EmblemHealth covers Ozempic depends heavily on which kind of plan you hold. They follow completely different rules — here's each one, side by side.
Medicare
Part D & Advantage plans
Medicare Advantage (EmblemHealth VIP): Ozempic is covered for type 2 diabetes with prior authorization. PA requires a documented T2D diagnosis and evidence of metformin step-therapy or a documented contraindication. The 2026 Part D out-of-pocket cap of $2,100 applies to covered drugs under the Part D benefit. EmblemHealth VIP Medicare Advantage enrollees cannot use the NovoCare savings card — federal anti-kickback rules exclude Medicare beneficiaries. The IRA Maximum Fair Price for semaglutide (Ozempic/Rybelsus/Wegovy) is $274 per 30-day supply, effective January 1, 2027. Ozempic is not covered for weight loss under Medicare Advantage — off-label weight-loss use is excluded.
Commercial / Employer
Group & marketplace plans
Commercial/Employer: EmblemHealth covers Ozempic for type 2 diabetes with prior authorization. Formulary tier is not publicly confirmed at the drug level — verify on EmblemHealth's drug-lookup tool or call member services. T2D patients on a commercial plan may be eligible for the NovoCare Ozempic Savings Card ($25 per fill, max $150 per 28-day supply) — verify at NovoCare.com. Not covered for off-label weight loss. ACA/Individual: covered for T2D with PA; not covered for weight loss. New York's insurance regulations are among the most consumer-protective in the country, which supports coverage of established T2D medications including Ozempic. Medicaid (EmblemHealth/HIP NY Medicaid): Ozempic is covered for type 2 diabetes with prior authorization at nominal Medicaid cost-share. Not covered for off-label weight loss. Medicaid enrollees cannot use the NovoCare savings card.
The 3 boxes you must tick to get approved
Commercial plans that will consider Ozempic require prior authorization. Check off what applies to you to see how close you are — this is a guide, not a guarantee of approval.
Meet all 3 and you have a documented case for approval. Missing any one is the most common reason requests are denied.
Your cost, three ways
What Ozempic actually costs you swings enormously depending on how it's covered. Here's the realistic range.
Paying cash
~$1,028/month (Novo Nordisk published pricing, ~$1,027.51 for the 0.25/0.5 mg pen). NovoCare self-pay: ~$199/month intro price (first two fills through December 31, 2026), then ~$349/month (0.25/0.5/1 mg) or ~$499/month (2 mg).
List price with no coverage — before any manufacturer savings card.
With coverage
Commercial: plan-specific cost-share — verify on EmblemHealth drug-lookup tool. Medicare Advantage: cost-share depends on plan tier and benefit phase; $2,100 Part D OOP cap applies in 2026. IRA Maximum Fair Price of $274/30-day for semaglutide takes effect January 1, 2027 for Medicare enrollees. Medicaid: nominal Medicaid cost-share.
Typical monthly copay once prior authorization is approved.
Bridge program
NovoCare Ozempic Savings Card: commercially insured T2D patients may pay as little as $25 per fill (max $150 per 28-day supply). Not available to Medicare, Medicaid, VA, DoD, or TRICARE beneficiaries. Verify eligibility at NovoCare.com.
Reduced copay through the assistance program, where eligible.
All figures are estimates — verify exact cost-share with EmblemHealth member services or on your plan's drug-lookup tool. Tier placement and cost-share vary by specific EmblemHealth plan and line of business.
Check YOUR exact coverage in 3 steps
General answers only get you so far. Here's how to confirm your own plan's decision in a few minutes.
- 1
Look up Ozempic on EmblemHealth's drug-lookup tool
Log in to your EmblemHealth member account at emblemhealth.com and use the formulary or drug-lookup tool to confirm Ozempic is on your specific plan's drug list, its tier, and any prior-authorization or step-therapy requirements. Formulary details vary by plan type (commercial, HMO, Medicare Advantage, Medicaid).
- 2
Have your prescriber initiate the prior-authorization request
Ask your provider to submit a PA request to EmblemHealth. The submission should include: a documented T2D diagnosis (ICD-10 E11.x), evidence of metformin use or a documented medical reason it cannot be used, and any additional step-therapy documentation required by your specific plan. The clinical indication must be type 2 diabetes — not weight management.
- 3
Check 2027 IRA pricing and savings-card eligibility
If you are on a commercial plan and have a T2D diagnosis, ask your pharmacist about the NovoCare savings card ($25/fill). If you are on Medicare Advantage, note that the IRA Maximum Fair Price of $274/30-day for semaglutide takes effect January 1, 2027. Call EmblemHealth member services at the number on your ID card for a personalized cost estimate.
Options if EmblemHealth won't cover Ozempic
A denial isn't the end of the road. These are the paths people commonly explore next — discuss any of them with your prescriber.
Rybelsus (oral semaglutide)
Oral semaglutide tablet for type 2 diabetes. Also covered for T2D on most commercial formularies with PA. Also subject to the IRA Maximum Fair Price of $274/30-day effective January 1, 2027. Verify tier on EmblemHealth drug-lookup.
Jardiance (empagliflozin)
SGLT-2 inhibitor commonly used as step-therapy oral agent before GLP-1 approval. Often at a lower cost-share tier than Ozempic on commercial formularies.
Metformin (generic)
First-line oral diabetes medication, universally covered at Tier 1 on commercial and Medicaid plans, typically at low or $0 copay. Required as step therapy before Ozempic PA approval in most plans.
Compounded semaglutide (weight-loss seekers only)
For patients seeking semaglutide for weight management — not T2D — who are denied coverage by EmblemHealth, compounded semaglutide from $49/mo is available at getcurex.com/cl/glp without insurance. See the Curex offer section below for full disclaimers.
These options are listed for information only — your own clinician decides what is appropriate for you.
❓Frequently Asked Questions
No. EmblemHealth does not cover Ozempic for weight loss under any line of business. Ozempic holds FDA approval for type 2 diabetes glycemic control, cardiovascular risk reduction in T2D patients with established heart disease, and kidney disease progression reduction in T2D patients with CKD — not for chronic weight management. Off-label weight-loss use is not a covered indication on any EmblemHealth commercial, ACA, Medicare Advantage, or Medicaid plan. Patients seeking semaglutide for weight management should explore other options.
Yes, EmblemHealth covers Ozempic for type 2 diabetes with prior authorization across its commercial, ACA, Medicare Advantage, and Medicaid plans. Your prescriber must submit a PA documenting a T2D diagnosis and evidence of metformin step-therapy or a documented contraindication. Formulary tier and specific cost-share are not publicly confirmed at the drug level — verify on EmblemHealth's drug-lookup tool or call member services for your specific plan details.
Commercially insured T2D patients on an EmblemHealth commercial plan may be eligible for the NovoCare Ozempic Savings Card ($25 per fill, max $150 per 28-day supply) — verify eligibility at NovoCare.com. Medicare Advantage and Medicaid enrollees cannot use the savings card; federal anti-kickback rules prohibit government program beneficiaries from using manufacturer copay cards. Most EmblemHealth commercial enrollees in the NYC area are eligible to verify and potentially use this card.
Under EmblemHealth commercial plans, cost-share depends on your plan's tier placement for Ozempic — verify on your plan's drug-lookup tool. Under EmblemHealth VIP Medicare Advantage, the 2026 Part D out-of-pocket cap limits maximum annual spending to $2,100. Starting January 1, 2027, the IRA Maximum Fair Price for semaglutide (Ozempic/Rybelsus/Wegovy combined) drops to $274 per 30-day supply for Medicare patients. Contact EmblemHealth member services for a personalized cost estimate.
New York has strong consumer-protective insurance regulations that support coverage of clinically established medications. EmblemHealth, as a New York-domiciled insurer, operates under these standards — which generally means established T2D medications like Ozempic are available through the standard prior-authorization process. This does not change the off-label weight-loss exclusion, which is universal across all insurers regardless of state regulation: Ozempic is not covered for weight management anywhere.
Related Articles
Does Aetna Cover Vyvanse? 2026 CVS Caremark Formulary
Aetna covers Vyvanse via CVS Caremark — generic lisdexamfetamine preferred, brand non-preferred. 70 mg/day QL per Policy 5.60.024; age-22 PA required.
Read moreDoes Aetna Cover Prolia? CVS Caremark Medical Benefit | Curex
Aetna covers Prolia under the medical benefit with PA — a q6-month clinic injection, not Part D. Jubbonti biosimilar now preferred on CVS Caremark.
Read moreDoes Anthem Cover Adderall? 2026 Coverage Guide | Curex
Anthem covers Adderall through CarelonRx — generic preferred, brand non-preferred. Step therapy may apply on some plans. Verify your Anthem plan.
Read moreDoes Anthem Cover Contrave? 2026 Brand Coverage Guide | Curex
Anthem covers Contrave only if your plan has a weight-loss benefit. Many plans carve it out. CurAccess ~$99/mo is often the fastest path.
Read moreDoes Aetna Cover Contrave? 2026 CVS Caremark Guide | Curex
Aetna (CVS Caremark) often excludes Contrave under AOM carve-outs. Where covered, CVS BMI prior auth applies. Medicare bars it by law. CurAccess ~$99/mo.
Read moreDoes Aetna Cover Forteo? 2026 Coverage Guide
Aetna (CVS) often excludes brand Forteo in favor of generic teriparatide or Bonsity. Teriparatide is covered with PA and bisphosphonate step therapy. 2026.
Read moreInsurance won't cover Ozempic for weight loss — here's a path that doesn't need it
EmblemHealth does not cover Ozempic for off-label weight loss. For New York patients searching 'does EmblemHealth cover Ozempic' who are weight-loss seekers rather than T2D patients, Curex offers compounded semaglutide starting at $49/mo with no insurance required and no prior authorization. Compounded tirzepatide is also available from $149/mo. Compounded semaglutide is not the same medication as Ozempic or Wegovy. Prescription required, subject to provider review.
- Medication + free shipping
- 24/7 provider access
- Medical intake & prescription review
Compounded semaglutide and tirzepatide are not the same medications as Ozempic and are not branded or FDA-approved products. Compounded medications have not been approved by the FDA and the FDA has not evaluated their safety or efficacy.
This content is for informational purposes only and does not constitute medical, financial, or insurance advice. Coverage rules, prior-authorization criteria, and copay amounts change frequently and vary by plan, formulary tier, and effective date — always verify current benefits directly with EmblemHealth before making any decision. Consult a licensed healthcare provider and your plan administrator for guidance specific to your situation. Curex offers compounded semaglutide and tirzepatide, which are not the same medications as Ozempic and are not branded or FDA-approved products; prescription required, subject to provider review. Compounded medications have not been approved by the FDA and the FDA has not evaluated their safety or efficacy.